Health Care [ 3/12 ] | Health Care Providers & Services [ 6/74 ]
NASDAQ | Common Stock
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States.
It provides diagnostic blood cancer testing services.
The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages.
It offers biomarker testing and clinical project services to bio-pharma customers.
Precipio, Inc. is based in New Haven, Connecticut.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 18, 26 | -0.81 Decreased by -231.14% | - |
| Nov 14, 25 | -0.05 Increased by +88.18% | - |
| Aug 13, 25 | 0.05 Increased by +106.00% | - |
| May 12, 25 | -0.59 Decreased by -190.31% | - |
| Mar 31, 25 | -0.24 Increased by +76.50% | 0.74 Decreased by -133.03% |
| Nov 11, 24 | -0.42 Decreased by -369.89% | - |
| Aug 13, 24 | -0.83 Decreased by -541.23% | - |
| May 14, 24 | 0.65 Increased by +751.40% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 6.30 M Increased by +48.04% | -1.44 M Decreased by -63.24% | Decreased by -22.90% Decreased by -10.27% |
| Dec 31, 25 | 7.97 M Increased by +46.31% | 526.00 K Increased by +244.11% | Increased by +6.60% Increased by +198.49% |
| Sep 30, 25 | 6.16 M Increased by +18.33% | -79.00 K Increased by +87.38% | Decreased by -1.28% Increased by +89.34% |
| Jun 30, 25 | 5.65 M Increased by +27.31% | 74.00 K Increased by +106.07% | Increased by +1.31% Increased by +104.76% |
| Mar 31, 25 | 4.26 M Increased by +24.04% | -884.00 K Increased by +57.48% | Decreased by -20.77% Increased by +65.72% |
| Dec 31, 24 | 5.45 M Increased by +25.90% | -365.00 K Decreased by -139.46% | Decreased by -6.70% Decreased by -131.34% |
| Sep 30, 24 | 5.21 M Increased by +39.35% | -626.00 K Increased by +56.98% | Decreased by -12.02% Increased by +69.13% |
| Jun 30, 24 | 4.44 M Increased by +25.70% | -1.22 M Increased by +46.79% | Decreased by -27.47% Increased by +57.67% |